Inverse dose proportionality: using breakthrough pain medication as a biological indicator for background analgesia escalation.

OBJECTIVE: To propose a "top-down" pharmacological hypothesis where the effective dose of rapid-onset opioids (ROOs) for breakthrough pain (BTP) serves as a mathematical predictor for required background analgesic adjustments. METHODS: We analyzed five opioid-tolerant cancer patients in a home-care setting with uncontrolled background pain. Instead of traditional reactive titration, a 1:6 inverse proportionality rule was applied, using the patient-identified effective BTP dose to calculate the new around-the-clock (ATC) dose. RESULTS: Rapid pain stabilization was achieved in patients within 24-48 h. Despite significant dose escalations (up to 300%), no clinical signs of opioid-induced neurotoxicity or respiratory depression were observed. CONCLUSION: The effective BTP dose may act as a "bio-indicator" of systemic opioid requirement. This hypothesis challenges the "start low, go slow" dogma, suggesting a more aggressive, patient-centered titration model that warrants formal prospective validation.